Physician profile
Michael A Covlin
NPI 1780641852
$3,025.18
in general payments reported to CMS, 2019-2025
32 companies · $562 in 2025
The $562 reported for 2025 was more than what 83% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $431 · 2020: $47.38 · 2021: $174 · 2022: $429 · 2023: $977 · 2024: $405 · 2025: $562.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,853 · Education: $90.95.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,852.54 |
| Education | $90.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $573.82 | 2019-2023 | Vraylar |
| Mayne Pharma Commercial LLC | $452.79 | 2022-2025 | |
| Organon LLC | $311.97 | 2022-2025 | Nexplanon, Jada System |
| Intuitive Surgical, INC. | $233.58 | 2023-2025 | Da Vinci Surgical System |
| Astellas Pharma US INC | $221.07 | 2023-2025 | Veozah, Myrbetriq |
| Exeltis, USA INC. | $157.05 | 2022-2025 | Slynd |
| Sage Therapeutics, LLC | $121.37 | 2024-2025 | Zurzuvae |
| Hologic Sales and Service, LLC | $120.65 | 2022-2025 | Third Wave, Thinprep 2000 Processor, Aptima |
| Novo Nordisk INC | $95.41 | 2022-2024 | Wegovy |
| Baxter Healthcare | $91.38 | 2019-2024 | Perclot |
| Ethicon US, LLC | $61.92 | 2019 | |
| Agile Therapeutics, INC. | $57.10 | 2022-2023 | Twirla |
| Gynesonics, INC. | $55.89 | 2023 | Sonata Sonography-Guided Transcervical Fibroid Ablation System |
| Bayer Healthcare Pharmaceuticals INC. | $55.64 | 2019-2023 | |
| Sumitomo Pharma America, INC. | $49.00 | 2023 | Myfembree |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Daiichi Sankyo INC. | $45.06 | 2019-2022 | |
| Millicent US INC | $35.25 | 2025 | Femlyv |
| Coopersurgical, INC. | $30.31 | 2019-2023 | Wallach Cryosurgical Equipment |
| Smith+Nephew, INC. | $28.82 | 2022-2023 | Pico 7 |
| Exact Sciences Corporation | $23.52 | 2023 | Cologuard Collection Kit |
| Axonics, INC. | $22.50 | 2021 | |
| Dexcom, INC. | $20.05 | 2023 | Dexcom G6 Transmitter |
| Allergan, INC. | $19.01 | 2019 | |
| Lsi Solutions INC | $18.11 | 2022 | |
| Convatec INC. | $17.92 | 2020 | |
| Supernus Pharmaceuticals, INC. | $17.85 | 2025 | Qelbree |
| Lilly USA, LLC | $16.21 | 2024 | Zepbound |
| Therapeuticsmd, INC. | $15.95 | 2022 | |
| Meditrina | $15.87 | 2023 | |
| Mylan Pharmaceuticals INC. | $14.48 | 2022 | |
| Avanos Medical | $14.47 | 2024 | On-Q* Pump and Accessories |
| Merck Sharp & Dohme LLC | $11.16 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Covlin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.